Richard Peet, Ph.D., is a retired partner and was an intellectual property lawyer with Foley & Lardner LLP. He counseled clients in the areas of patent and trademark procurement and enforcement as well as structuring license and joint venture deals, with a focus on technological developments in the fields of chemistry, nanotechnology and biotechnology. Dr. Peet has extensive experience in assisting clients with worldwide patent protection strategies as well as U.S. patent interferences, patent litigation and appellate practice. He is former chair of the firm’s International and formerly named Chemical & Pharmaceutical Practices. He was also a member of the Chemical, Biotechnology & Pharmaceutical Practice and the Life Sciences Industry Team.

Dr. Peet has represented clients in numerous patent enforcement litigations involving complex technologies in the fields of chemistry, pharmaceuticals and biotechnology. Many of these litigations have involved development of worldwide patent strategies.

Dr. Peet has supervised more than 75 intellectual property due diligence projects related to acquisitions ranging in value from $70 million to more than $900 million. Dr. Peet has conducted intellectual property due diligence on behalf of numerous venture capital companies. The technologies involved in these transactions include biotechnology, pharmaceuticals, medical device, nanotechnology and agriculture. Dr. Peet has represented foreign companies seeking to purchase U.S. assets as well as U.S. companies acquiring foreign assets. During the course of these projects, he has coordinated the legal work of foreign law firms on behalf of his clients and worked as a member of large due diligence teams.

Before entering the practice of law, Dr. Peet was a research scientist with the Department of Microbiology, Free University, Amsterdam, The Netherlands, and Sandoz.